D-192-2013 Class II Terminated
FDA drug recall D-192-2013 was initiated by K C Pharmaceuticals Inc on Mar 1, 2010 and is designated Class II. Reason for recall: Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and… The recall status is terminated (terminated Apr 2, 2013). Affected quantity: 31,704 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 20, 2013
- Initiation Date
- Mar 1, 2010
- Termination Date
- Apr 2, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,704 bottles
Product description
Eye Drops advanced relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl 0.05%) ophthalmic solution, 1/2 fl oz (15 mL) bottle, Distributed By Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37072.
Reason for recall
Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and povidone.
Distribution pattern
Nationwide
Code information
Lot #: 9P367, Exp 12/12
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-192-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026